Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)

Recruiting now · Not applicable

Conditions studied: HIV Prevention, HIV Related Stigma, PrEP Adherence

In brief

This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.

Key facts

Study ID

NCT07509827

Run by

Institute of HIV Research and Innovation Foundation, Thailand

People needed

108

Starts

2024-08-01

Expected to finish

2028-07-31

Last updated by the study team

2026-04-03

Who can join

Age: 18 and older, up to 29. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-29 years
• Male sex at birth
• Self-identify as transgender woman/female spectrum
• HIV-negative (laboratory confirmed)
• Recent condomless sex
• Able to understand Thai
• Not on PrEP or poorly adherent (≤3 pills/week)

You may not qualify if…

• Serious cognitive or psychiatric condition affecting consent
• Active suicidal ideation or major mental illness
• Medical contraindications to PrEP
• Enrolled in another HIV intervention study

Where it is running

• Rainbow Sky Association of Thailand (RSAT) — Bangkok, Bangkapi, Thailand (enrolling)
• The Service Workers In Group Foundation (SWING) — Bangkok, Building 3, Patpong, Surawong Road, Thailand (enrolling)
• Institute of HIV Research and Innovation (IHRI) — Bangkok, Pathumwan, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.